Literature DB >> 28431716

Invasive Medullary Type A Thymoma With Recurrent Distant Metastases.

Maria Cecilia Mengoli1, Lucia Longo2, Susanna Varini1, Giulio Rossi3, Filippo Lococo4.   

Abstract

Thymomas are rare epithelial mediastinal tumors showing a certain propensity for local and intrathoracic recurrences. Otherwise, extrathoracic metastases are very rarely reported and are usually associated with type B thymomas or thymic carcinomas. We present a challenging patient with an invasive (Masaoka-Koga stage IIb) medullary type A thymoma with recurrent extrathoracic metastases (pulmonary and vertebral localizations occurring 2 and 7 years after the initial radical thymectomy, respectively). Despite type A thymoma being considered a low-grade malignancy with a scarce propensity to recurrence, the present case should alert clinicians to the possibility of bone metastasis. Long-term follow-up in this slow-growing neoplasm is then mandatory.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28431716     DOI: 10.1016/j.athoracsur.2016.11.018

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Immunohistochemistry biomarker TP53 expression predicts the survival of thymomas.

Authors:  Dongliang Bian; Liting Zhao; Xuelin Zhang; Fanzhen Lv; Zhenghong Zhu; Hui Qiu; Huibiao Zhang
Journal:  Gland Surg       Date:  2020-04

2.  The secondary surgery provides significant benefits to recurrent thymoma: a retrospective analysis based on Surveillance, Epidemiology and End Results database.

Authors:  Dongliang Bian; Tao Ge; Nan Song; Peng Zhang; Helin Zhang; Ke Fei
Journal:  Transl Cancer Res       Date:  2019-06       Impact factor: 1.241

3.  Small-sized type A thymoma with pulmonary metastasis: a case report.

Authors:  Sachi Kawagishi; Tomohiro Maniwa; Hirokazu Watari; Ryuhei Sakata; Akiisa Omura; Ryo Tanaka; Toru Kimura; Keiichiro Honma; Jiro Okami
Journal:  Surg Case Rep       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.